Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K4QW
|
||||
Former ID |
DNC009743
|
||||
Drug Name |
1,3-bis(nitrooxy)propan-2-yl 2-acetoxybenzoate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530105] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H12N2O10
|
||||
Canonical SMILES |
CC(=O)OC1=CC=CC=C1C(=O)OC(CO[N+](=O)[O-])CO[N+](=O)[O-]
|
||||
InChI |
1S/C12H12N2O10/c1-8(15)23-11-5-3-2-4-10(11)12(16)24-9(6-21-13(17)18)7-22-14(19)20/h2-5,9H,6-7H2,1H3
|
||||
InChIKey |
KDHWEMULLOVCEH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [530105] | |
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
NF-kappa B signaling pathway | |||||
VEGF signaling pathway | |||||
TNF signaling pathway | |||||
Retrograde endocannabinoid signaling | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Oxytocin signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Leishmaniasis | |||||
Pathways in cancer | |||||
Chemical carcinogenesis | |||||
MicroRNAs in cancer | |||||
Small cell lung cancer | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.